Catalyze Capital is a closed-end fund that invests in early-stage innovative companies across Europe, primarily focusing on the Life Science, Sustainable, and Deep Tech sectors. The fund provides investments of up to €1.5 million to small-to-medium enterprises and academic spin-offs in Seed and Series A stages, promoting the development of impactful technologies that benefit both people's health and the planet.